C4 Therapeutics
Adrian Bignami is currently the Vice President of Finance, Business Planning and Analysis at C4 Therapeutics, Inc. Prior to this role, Adrian held various financial positions at Vertex Pharmaceuticals and worked in investment banking at Goldman Sachs. Adrian also co-founded Nordic Scientific, a company focused on developing technologies for disinfectant, antiseptic, and bleaching markets. Adrian's academic background includes a BS in Bio-Engineering and Economics from Brown University, an SM in Biomedical Enterprise Program from Harvard-MIT Health Sciences and Technology, and an MBA from MIT Sloan School of Management. Adrian's early career includes experience as a Consultant at Putnam Associates and research internships at Brigham and Women's Hospital.
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.